AbbVie reports Q2 2026 revenue growth and updates EPS guidance
AbbVie reported Q2 2026 net revenues of $16.99 billion, a 10.2% increase, and updated its adjusted EPS guidance to $13.87-$14.07.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day